Evoke Pharma Shares Soar on Positive Data for Gimoti Nasal Treatment in Diabetic Gastroparesis

By Yahoo! Finance | Oct 28, 2024 at 01:39 PM EST

Evoke Pharma's stock soared 90% on Monday due to positive results of its nasal medicine, Gimoti, for diabetic gastroparesis. The study compared healthcare resource use for Gimoti and oral metoclopramide, highlighting the benefit of nasal delivery for patients with stomach paralysis.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.